Consistent with its action in NASH, adropin overexpression or treatment in NAFLD animal models has been shown to alleviate palmitic acid-induced oxidative stress in hepatocytes (78). The gene discussed is ENHO; the disease is metabolic dysfunction-associated steatotic liver disease.